Extracorporeal Membrane Oxygenation Ecmo Systems Market Report
First published: 21 October 2024 | Last updated: 25 May 2026 | Report Code: extracorporeal-membrane-oxygenation-ecmo-systems
Extracorporeal Membrane Oxygenation Ecmo Systems Market — USD 3.5 billion in 2023, Growing to USD 6.68B by 2033 at 6.5% CAGR
This report provides insights into the Extracorporeal Membrane Oxygenation (ECMO) Systems market from 2023 to 2033. It includes market size, trends, segmentation, regional analysis, and profiles of key players, offering a comprehensive view of the industry's landscape and future projections.
Key Takeaways
- Global market expands from $3.50 Billion (2023) to $6.68 Billion (2033) at a 6.5% CAGR.
- Europe is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe holds the largest regional share, increasing from $1.28 Billion to $2.45 Billion over the forecast.
- North America grows from $1.13 Billion to $2.15 Billion, reflecting strong demand in advanced healthcare settings.
- Asia Pacific advances from $0.66 Billion to $1.27 Billion, driven by expanding critical care capacity.
- Leading vendors include Maquet Cardiopulmonary, Getinge Group, Fresenius SE & Co. KGaA, Medtronic, and LivaNova PLC.
Extracorporeal Membrane Oxygenation Ecmo Systems Market Report — Executive Summary
Europe remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report examines the Extracorporeal Membrane Oxygenation (ECMO) systems market across technology, application, end-user, and geography. The market value is projected to climb from $3.50 Billion in 2023 to $6.68 Billion in 2033 at a 6.5% CAGR. Expansion is supported by rising incidence of severe cardiac and respiratory conditions, investment in critical care infrastructure, and device innovation that improves monitoring and portability. Segmentation covers veno-venous, veno-arterial, and arterio-venous technologies; applications in cardiac and pulmonary support; and end-users such as hospitals, ambulatory surgical centers, and pre-hospital settings. Europe is identified as the largest regional market. The competitive landscape lists major manufacturers including Maquet Cardiopulmonary, Getinge Group, Fresenius SE & Co. KGaA, Medtronic, and LivaNova PLC. The analysis highlights product development, clinical adoption, and workforce training as central factors shaping market outcomes through 2033.
Key Growth Drivers
- Rising prevalence of severe respiratory and cardiac disorders increasing clinical demand for ECMO intervention.
- Continued technological improvements in portability and monitoring that broaden clinical applications and emergency deployment.
- Expansion of critical care infrastructure and investments in advanced life-support capabilities across hospital systems.
- Greater awareness and clinical adoption of ECMO protocols among specialized care teams and referral networks.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $3.50 Billion |
| CAGR (2023-2033) | 6.5% |
| 2033 Market Size | $6.68 Billion |
| Top Companies | Maquet Cardiopulmonary, Getinge Group, Fresenius SE & Co. KGaA, Medtronic , LivaNova PLC |
| Published Date | 21 October 2024 |
| Last Modified Date | 25 May 2026 |
Extracorporeal Membrane Oxygenation Ecmo Systems Market Overview
Customize Extracorporeal Membrane Oxygenation Ecmo Systems Market Report market research report
- ✔ Get in-depth analysis of Extracorporeal Membrane Oxygenation Ecmo Systems market size, growth, and forecasts.
- ✔ Understand Extracorporeal Membrane Oxygenation Ecmo Systems's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Extracorporeal Membrane Oxygenation Ecmo Systems
What is the Market Size & CAGR of Extracorporeal Membrane Oxygenation Ecmo Systems Market Report market in 2023?
Extracorporeal Membrane Oxygenation Ecmo Systems Industry Analysis
Extracorporeal Membrane Oxygenation Ecmo Systems Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Extracorporeal Membrane Oxygenation Ecmo Systems Market Report Market Analysis Report by Region
Europe Extracorporeal Membrane Oxygenation Ecmo Systems Market Report:
Europe is largest regional market, rising from $1.28 Billion in 2023 to $2.45 Billion in 2033. Regional demand is driven by established critical care systems, clinical adoption of ECMO, and ongoing innovation among local and international suppliers.Asia Pacific Extracorporeal Membrane Oxygenation Ecmo Systems Market Report:
Asia Pacific grows from $0.66 Billion in 2023 to $1.27 Billion in 2033. Growth is linked to expanding healthcare infrastructure, increasing critical care access, and greater clinical awareness of ECMO applications in severe cardiorespiratory conditions.North America Extracorporeal Membrane Oxygenation Ecmo Systems Market Report:
North America grows from $1.13 Billion in 2023 to $2.15 Billion in 2033. Expansion reflects advanced hospital capacity, adoption of ECMO protocols, and investment in critical care technologies that support broader clinical use in acute cardiac and respiratory cases.South America Extracorporeal Membrane Oxygenation Ecmo Systems Market Report:
Latin America grows from $0.03 Billion in 2023 to $0.05 Billion in 2033. Market movement is supported by gradual expansion of tertiary care facilities and selective adoption of advanced life-support systems in regional centers.Middle East & Africa Extracorporeal Membrane Oxygenation Ecmo Systems Market Report:
Middle East and Africa grows from $0.45 Billion in 2023 to $0.86 Billion in 2033. Drivers include investments in specialized care units, upgrades to intensive care capabilities, and targeted procurement of life-support technologies.Tell us your focus area and get a customized research report.
Research Methodology
Extracorporeal Membrane Oxygenation Ecmo Systems Market Analysis By Technology
The ECMO market by technology is primarily segmented into veno-venous, veno-arterial, and arterio-venous ECMO systems. Veno-venous ECMO leads this segment, accounting for 61.62% market share in 2023, with a projected growth to 61.62% by 2033. Veno-arterial ECMO holds a 22.23% share, significant for cardiac care, while arterio-venous ECMO, accounting for 16.15%, is utilized less frequently.
Extracorporeal Membrane Oxygenation Ecmo Systems Market Analysis By Application
In terms of application, the ECMO systems are used for cardiac and pulmonary support. Cardiac support applications dominate with a 61.62% share in 2023, growing to an equal share in 2033. Pulmonary support follows at 22.23%, also expecting similar stability in the long term, while congenital heart disease cases account for 16.15% of application use.
Extracorporeal Membrane Oxygenation Ecmo Systems Market Analysis By End User
The end-user market is prevalent in hospitals with a notable 61.62% share in 2023, which is expected to hold steady over the forecast duration. Ambulatory surgical centers account for 22.23% and pre-hospital settings at 16.15%, which are both critical in the initial response to medical emergencies.
Extracorporeal Membrane Oxygenation Ecmo Systems Market Analysis By Region
Regional segmentation shows divergent trends with North America leading at 43.84% market share in 2023, expected to remain stable. Europe follows with a 23.69% share, while the Asia-Pacific region captures 11.15%. Latin America and Middle East & Africa hold shares of 11.28% and 10.04%, respectively.
Extracorporeal Membrane Oxygenation Ecmo Systems Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Extracorporeal Membrane Oxygenation Ecmo Systems Industry
Maquet Cardiopulmonary:
A leader in the ECMO market, Maquet offers a comprehensive range of ECMO solutions known for their reliability and advanced technology, contributing significantly to critical care practices globally.Getinge Group:
Known for its innovative medical technology, Getinge Group provides a variety of ECMO devices, enhancing patient outcomes through improved equipment aimed at critically ill patients.Fresenius SE & Co. KGaA:
Fresenius is a prominent manufacturer in the ECMO field, focusing on high-quality and efficient systems designed for use in intensive care environments across the globe.Medtronic :
Medtronic's ECMO systems are pivotal in the market, characterized by their advanced technological features and commitment to patient-centric solutions in acute care.LivaNova PLC:
LivaNova specializes in ECMO technology, providing devices that are critical for both cardiac and respiratory support, positioned as key players within the industry.We're grateful to work with incredible clients.
FAQs
What is the market size of the Extracorporeal Membrane Oxygenation Ecmo Systems Market Report in 2023?
The market size for 2023 is $3.50 Billion, as stated for the base year in the report's scope and headline figures.
How big will the market be in 2033?
By 2033 the market is projected to reach $6.68 Billion according to the report's forecast period outcomes.
What is CAGR for the forecast period?
The reported compound annual growth rate for the 2023 to 2033 forecast period is 6.5%.
Why is Europe identified in the report?
Europe is noted as the largest regional market, increasing from $1.28 Billion in 2023 to $2.45 Billion in 2033, reflecting substantial regional demand.
Which companies are listed as top players?
Top companies named include Maquet Cardiopulmonary, Getinge Group, Fresenius SE & Co. KGaA, Medtronic, and LivaNova PLC.
Who are the primary end users covered in the segmentation?
End-user segmentation covers hospitals, ambulatory surgical centers, and pre-hospital settings as primary deployment environments.
What technologies are included in the technology segmentation?
Technology segments include veno-venous ECMO, veno-arterial ECMO, and arterio-venous ECMO, reflecting major clinical device types.
How big is the North America regional market in 2023?
North America is reported at $1.13 Billion in 2023, growing to $2.15 Billion by 2033 as per regional figures.
What drives adoption of ECMO systems in hospitals?
Adoption in hospitals is driven by increased critical care capacity, clinical protocols for severe cardiac and respiratory failure, and technology improvements.
Is there a single fastest Growing region in the Extracorporeal Membrane Oxygenation Ecmo Systems Market Report market?
No single fastest-growing region is stated for the Extracorporeal Membrane Oxygenation Ecmo Systems Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.